Dear All:
As you may know, the G20 are establishing an AMR R&D Hub that will encourage and promote coordinated global action on AMR. The hub will be based in the Berlin office of the German Center for Infection Research (DZIF) and Germany will finance it for the first three years. There is now a public call to recruit the leader of this hub. Here is the key text from the the online job description (emphasis is mine):
In their Declaration from July 7 and 8, 2017 the G20 Leaders “call for a new international R&D Collaboration Hub to maximize the impact of existing and new antimicrobial basic and clinical research initiatives as well as product development”. This Global AMR R&D Hub shall promote high-level coordination and alignment of the existing public and private funding and leverage further investments for AMR R&D initiatives on a national and/or international level. The Global AMR R&D Hub shall become a central platform to provide guidance for governments and non-governmental funders on R&D funding priorities in the field. The scope of the Global AMR R&D Hub is embedded in a comprehensive One Health Approach, comprising human and animal health as well as environmental aspects. Initially, the activities of the Global AMR R&D Hub shall focus on enabling the development of urgently needed products for the prevention, treatment and diagnosis of bacterial infections in humans.
For the implementation of the Global AMR R&D Hub a secretariat with up to five employees (including the position announced below) will be established within the German Center for Infection Research (DZIF) in Berlin, Germany. We are currently searching for one Secretariat Lead (Senior Level).
Could this be you or somebody you know? Please be sure to share this interesting and important job opportunity! All best wishes, –jr
John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: https://13.43.35.2/blog/
Upcoming meetings of interest to the AMR community:
- 12-14 Feb 2018 (Baltimore): ASM Biothreats Conference
- 28 Feb 2018 (Brussels): Deadline for responses to IMI2 Call 13 (Topic 3) on AMR diagnostics
- 2 Mar 2016 (Berlin): BEAM-sponsored 1-day “Big Drugs for Bad Bugs” conference
- 11-16 Mar 2018 (Ventura Beach): Gordon Research Conference on Antibacterial Discovery
- 12-13 Mar 2018 (London): BSAC’s Spring Conference
- 27-29 Mar 2018 (Cardiff, UK): BSAC-sponsored 3-day residential Workshop on Susceptibility Testing
- 16 Apr 2018 (Washington): Duke-Margolis & FDA event: “Evaluating Inclusion and Exclusion Criteria in Clinical Trials”
- 21-24 Apr 2018 (Madrid): ECCMID
- [NEW] 4-7 Jun 2018 (Boston): BIO (multiple AMR-focused sessions are expected)
- 7-11 Jun 2018 (Atlanta): ASM Microbe
- 22-27 Jul 2018 (Bryant University, Smithfield, RI): Gordon Research Conference on Drug Resistance for Cancer, Infectious Disease and Agriculture
- [Don’t miss this one] 4-7 Sep 2018 ESCMID-ASM Conference (#3) on Drug Development for AMR (Lisbon, Portugal) (initial flyer)
- 6-14 Oct 2018 International Course on Antibiotics and Resistance (ICARe, Les Pensières, Annecy, France)
